Medicines Containing The Active Substance Natalizumab (Atc: L04Ag03)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 90980612

  Document Type - Tender Notices

Description - Description: Scope of procurementBrief descriptionThe subject of this publication is the conclusion of non-exclusive discount agreements pursuant to Section 130a Para. 8 SGB V for finished medicinal products containing the active ingredient Natalizum ab (ATC: L04AG03) within the framework of a so-called "open-house model". Under the specification of uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or groups of pharmaceutical companies are offered the opportunity to conclude or join a discount agreement pursuant to Section 130a Para. 8 SGB V for the aforementioned active ingredients or medicinal products. Interested pharmaceuti

Mt Ref Id - 90980612

Deadline - Jul 31, 2026